Sernova Biotherapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 4, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Cap	47	50	81	231	243	326
Market Cap Growth	-27.74%	-38.61%	-64.72%	-5.00%	-25.66%	480.49%
Enterprise Value	51.98	54.44	75.89	210.86	193.17	298.94
Last Close Price	0.14	0.15	0.25	0.76	0.80	1.25
PE Ratio	-	-	2.50	5.85	8.89	41.67
PB Ratio	-1.89	-1.99	-6.28	18.42	5.10	11.63
P/TBV Ratio	-	-	-5.92	18.42	4.60	10.93
P/FCF Ratio	-	-4.58	-4.30	-7.57	-16.45	-47.58
P/OCF Ratio	-	-4.58	-4.30	-7.60	-16.83	-47.70
EV/EBITDA Ratio	-	-3.71	-2.44	-5.26	-7.94	-44.82
EV/EBIT Ratio	-	-3.62	-2.40	-5.21	-7.80	-43.10
EV/FCF Ratio	-	-4.99	-4.02	-6.93	-13.10	-43.57
Debt / Equity Ratio	-0.19	-0.19	-0.04	0.01	0.01	0.01
Debt / EBITDA Ratio	-0.32	-0.32	-0.02	0.00	-0.01	-0.06
Debt / FCF Ratio	-0.44	-0.44	-0.03	0.00	-0.02	-0.06
Net Debt / Equity Ratio	-0.18	-0.18	0.42	-1.57	-1.04	-0.98
Net Debt / EBITDA Ratio	-0.31	-0.31	0.18	0.49	2.04	4.12
Net Debt / FCF Ratio	-0.41	-0.41	0.29	0.65	3.36	4.01
Quick Ratio	0.02	0.02	0.32	2.17	10.74	19.19
Current Ratio	0.02	0.02	0.32	2.19	10.78	19.19
Return on Equity (ROE)	82.79%	82.79%	14564.17%	-129.73%	-64.54%	-43.25%
Return on Assets (ROA)	-364.20%	-364.20%	-213.74%	-108.60%	-60.15%	-39.03%
Return on Invested Capital (ROIC)	77.50%	77.50%	247.87%	895.40%	3797.29%	-933.78%
Return on Capital Employed (ROCE)	82.27%	82.27%	-239776.93%	-134.42%	-65.07%	-41.80%
Earnings Yield	-33.16%	0.00%	40.00%	17.11%	11.25%	2.40%
FCF Yield	-	-21.85%	-23.23%	-13.20%	-6.08%	-2.10%
Buyback Yield / Dilution	-0.50%	-0.50%	-6.12%	0.00%	-15.05%	-9.16%

Updated Oct 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.